Home / Lamivudine / United States
US ATC J05AF05 · updated 2 Nov 2026
Lamivudine shortage in United States
Is there a Lamivudine shortage in United States?
Yes. As of 2 Nov 2026, 2 Lamivudine products are reported short in United States, the first since 19 Oct 2026. No return date has been given. Main reason: not stated.
Also short in Italy, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Epivir, Tablet, 150 mg (NDC 49702-203-18) anticipated discontinuation | ViiV Healthcare Company | 19 Oct 2026 | not given | Not stated |
| US | Epivir, Tablet, 300 mg (NDC 49702-204-13) anticipated discontinuation | ViiV Healthcare Company | 19 Oct 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).